Paper · 3923951
Reduction of peripheral blood lymphocytes in patients receiving gold therapy for rheumatoid arthritis.
Hanly JG and 1 other. Ann Rheum Dis, 1985. Cited by 13 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Reduction of peripheral blood lymphocytes in patients receiving gold therapy for rheumatoid arthritis. Papers, record 3923951. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3923951
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reduction of peripheral blood lymphocytes in patients receiving gold therapy for rheumatoid arthritis.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Gold Sodium Thiomalate | Major topic |
| Leukocyte Count | Major topic |
| Lymphocytes | Major topic |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 838,859 | Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds. | J Clin Invest | 1977 | https://conductscience.org/library/papers/838859 | PubMed |
| 2 | 406,862 | Inhibition by gold of human lymphocyte stimulation. An in vitro study. | Ann Rheum Dis | 1977 | https://conductscience.org/library/papers/406862 | PubMed |
| 3 | 302,707 | Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. | Arthritis Rheum | 1977 | https://conductscience.org/library/papers/302707 | PubMed |
| 4 | 7,221,396 | The assessment of disease activity in rheumatoid arthritis using a multivariate analysis. | Rheumatol Rehabil | 1981 | https://conductscience.org/library/papers/7221396 | PubMed |
| 6 | 6,979,629 | Evaluation of T cell subsets with monoclonal antibodies in patients with rheumatoid arthritis. | J Rheumatol | 1982 | https://conductscience.org/library/papers/6979629 | PubMed |
| 7 | 6,224,467 | Analysis of T cell subsets in the peripheral blood and synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies. | Ann Rheum Dis | 1983 | https://conductscience.org/library/papers/6224467 | PubMed |
| 8 | 6,235,068 | Enhanced T helper cell function for the spontaneous production of IgM rheumatoid factor in vitro in rheumatoid arthritis. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6235068 | PubMed |
| 9 | 7,020,704 | Lymphapheresis in rheumatoid arthritis. A randomized trial. | Arthritis Rheum | 1981 | https://conductscience.org/library/papers/7020704 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 3,579,394 | Failure to show a fall in peripheral blood lymphocytes in patients receiving gold or penicillamine for rheumatoid arthritis. | Ann Rheum Dis | 1987 | https://conductscience.org/library/papers/3579394 | PubMed |
| 3,125,797 | Effects of chrysotherapy on circulating lymphocyte numbers and subsets. | Ann Rheum Dis | 1988 | https://conductscience.org/library/papers/3125797 | PubMed |
| 3,099,556 | Unique properties of auranofin as a potential anti-rheumatic drug. | Agents Actions | 1986 | https://conductscience.org/library/papers/3099556 | PubMed |
| 3,086,003 | The immunological consequences of gold therapy: a prospective study in patients with rheumatoid arthritis. | Clin Exp Immunol | 1986 | https://conductscience.org/library/papers/3086003 | PubMed |
| 2,778,779 | Lymphopenia in rheumatoid arthritis. | J R Soc Med | 1989 | https://conductscience.org/library/papers/2778779 | PubMed |
| 1,540,014 | Effect of sodium aurothiomalate on carrageenan induced inflammation of the air pouch in mice. | Ann Rheum Dis | 1992 | https://conductscience.org/library/papers/1540014 | PubMed |
| 1,351,061 | Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C. | J Clin Invest | 1992 | https://conductscience.org/library/papers/1351061 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3923951
GET https://conductscience.org/api/papers/v1/3923951/authors